Press Releases May 4, 2026 08:30 AM

Dentsply Sirona Launches Smart View - Detect, World’s First FDA-Cleared AI-enabled diagnostic aid for detecting teeth with Periapical Radiolucencies in CBCTs

Dentsply Sirona Launches Smart View - Detect, the First FDA-Cleared AI Diagnostic Aid for Detecting Periapical Radiolucencies in CBCT Scans

By Hana Yamamoto XRAY
Dentsply Sirona Launches Smart View - Detect, World’s First FDA-Cleared AI-enabled diagnostic aid for detecting teeth with Periapical Radiolucencies in CBCTs
XRAY

Dentsply Sirona has introduced Smart View - Detect, the world's first FDA-cleared AI-enabled diagnostic aid designed to enhance the detection of teeth affected by periapical radiolucencies (PARLs) in CBCT scans. This AI support feature increases detection sensitivity by approximately 46%, supports efficient review of complex dental imaging data, and improves communication between clinicians and patients. Integrated into the DS Core cloud platform, Smart View - Detect is compatible with existing Dentsply Sirona CBCT systems and will be available in the US and Europe starting May 2026.

Key Points

  • Smart View - Detect improves detection sensitivity of periapical radiolucencies by ~46% without increasing false positives, enhancing diagnostic accuracy for dental practitioners.
  • The AI tool facilitates better patient communication by visually highlighting potential areas of concern directly on CBCT images, supporting informed discussions and treatment planning.
  • Integration with DS Core cloud platform allows wide compatibility with Dentsply Sirona's CBCT systems, enabling seamless adoption without requiring new hardware purchases.

Smart View - Detect is associated with a ~46% relative increase1 in detection of teeth with periapical radiolucencies (PARLs) and supports efficient CBCT review and clearer patient communication. Available through DS Core2, Smart View - Detect is compatible with both newly installed and existing Dentsply Sirona CBCT systems.

CHARLOTTE, N.C., May 04, 2026 (GLOBE NEWSWIRE) -- Dentsply Sirona, the world’s largest manufacturer of professional dental products and technologies, today announced the launch of Smart View - Detect, the world’s first FDA Cleared AI-enabled diagnostic aid for detecting teeth with PARL in CBCTs, also CE approved in Europe. The AI-assisted support feature is designed to help clinicians review CBCT scans more efficiently and clearly when evaluating potential periapical radiolucencies (PARLs).

Periapical radiolucencies (PARLs) are a common clinical finding, with published research3 showing that approximately 52% of adults have at least one tooth affected. PARLs often require endodontic treatment, underscoring the importance of accurate detection and review.

While CBCT imaging is widely recognized for its diagnostic value, reviewing the depth of information contained in full 3D volumes can feel intimidating in everyday practice. Smart View – Detect is designed to help reduce the risk of overlooked findings by visually highlighting specific areas within CBCT scans where potential PARLs may be present. This supports efficient review and helps patients more easily understand what their dentist is seeing.

In an internal multi-reader, multi-case clinical study comparing AI-assisted versus unaided CBCT review, clinicians using Smart View - Detect increased tooth-level PARL detection sensitivity by approximately 46% relative to unaided review, without meaningfully increasing false positives.

Supporting Clearer Patient Conversations

Beyond review support, Smart View - Detect also enhances communication with patients by visually highlighting areas of interest directly within CBCT scans. This clarity helps patients easily understand what their dentist is seeing, supporting informed, confident, and productive treatment discussions. While Smart View - Detect does not provide a diagnosis, its visual presentation can help strengthen understanding, engagement, and trust during consultations.

“Smart View - Detect is designed to support dentists at two important moments—when reviewing complex CBCT data and when explaining findings to patients,” said Wolf-Dieter Perlitz, Senior Director DS Core at Dentsply Sirona. “By bringing a first of its kind AI-based diagnosis support into DS Core, we continue to advance the value of Connected Dentistry, helping clinicians feel confident in their evaluations, work more efficiently, and communicate more clearly with patients.”

DS Core: Reducing Digital Complexity to Support Efficient, High-Quality Care

Smart View - Detect is available through DS Core, Dentsply Sirona’s cloud-based platform, allowing AI-supported insights to be accessed directly as part of its imaging workflow. Through DS Core, Dentsply Sirona is working to reduce the operational and clinical complexity associated with digital dentistry by continuously evolving the platform, expanding its capabilities, and applying insights from real-world use to support more efficient workflows and informed clinical decision making.

Availability, Integration, and System Compatibility

Smart View - Detect is available for both newly installed and existing compatible Dentsply Sirona CBCT systems, including Orthophos S, Orthophos SL, and Axeos. Customers with a DS Core account can benefit from Smart View - Detect as an added capability within their existing setup, without the need to purchase new imaging equipment.

The feature supports all fields of view from 5×5 to 17×11 and works with both newly acquired and historical CBCT scans transferred from Sidexis 4 into DS Core.

Smart View - Detect will be available starting May 12, 2026, in the United States and Europe, and requires a DS Core Standard or Advanced subscription.

For more information, visit: DS Core - Diagnose Features: Smart View – Detect - YouTube

Registered brands, trade names and logos are used. Even in particular cases, when they appear without a TM or ®, all corresponding legal rules and provisions apply. All rights are retained by Dentsply Sirona. Clinicians may have been compensated for use of their experiences and testimonials.

About Dentsply Sirona

Dentsply Sirona is the world’s largest diversified manufacturer of professional dental products and technologies, with over a century of innovation and service to the dental industry and patients worldwide. Dentsply Sirona develops, manufactures, and markets a comprehensive solutions offering including dental and oral health products as well as other consumable medical devices under a strong portfolio of world-class brands. Dentsply Sirona’s innovative products provide high-quality, effective and connected solutions to advance patient care and deliver better and safer dental care. Dentsply Sirona is headquartered in Charlotte, North Carolina. The Company’s shares are listed in the United States on Nasdaq under the symbol XRAY. Visit www.dentsplysirona.com for more information about Dentsply Sirona and its products.

Contact Information:

Dentsply Sirona Press Contact:
Marion Par-Weixlberger
Vice President, Corporate Communications, Public Relations & Brand
[email protected] | www.dentsplysirona.com

1 Based on results from an internal multi-reader, multi-case clinical study evaluating AI-assisted versus unassisted CBCT readings for periapical radiolucency detection.
2 Requires DS Core Standard tier or above
3 https://pubmed.ncbi.nlm.nih.gov/33378579/


Risks

  • The AI diagnostic aid does not provide a conclusive diagnosis but only supports detection, which may still require clinician interpretation, potentially limiting impact on diagnostic certainty.
  • Adoption depends on clinicians subscribing to DS Core Standard or Advanced tiers, which could limit uptake among existing users not wanting to change their platform subscriptions.
  • Any unforeseen limitations or accuracy issues in real-world use beyond the internal study could affect clinician trust and patient outcomes, impacting reputation and device utilization.

More from Press Releases

TWFG Insurance Acquires APIA Inc., Expanding Specialty MGA Capabilities and Supporting Long-Term Growth May 4, 2026 Pennant Announces First Quarter 2026 Earnings Release and Call May 4, 2026 Magna Announces 2026 Annual Meeting Results May 4, 2026 Sprott Physical Copper Trust Updates Its “At-The-Market” Equity Program in Connection with NYSE Arca Listing May 4, 2026 Grupo Aeroportuario del Pacifico Reports on Impact Arising from the Cessation of Operations of Spirit Airlines May 4, 2026